Fig. 7: Validation and recalibration of the BileLipid classifier. | British Journal of Cancer

Fig. 7: Validation and recalibration of the BileLipid classifier.

From: Lipidomic profiling of human bile distinguishes cholangiocarcinoma from benign bile duct diseases with high specificity and sensitivity: a prospective descriptive study

Fig. 7

a Heatmap of the normalised abundance of the 6 lipid features across the 3 cohorts. b Intergroup comparison of the relative concentrations of the 6 lipids in Cohort 3 using targeted lipid quantification (Wilcoxon rank-sum test). c Diagnostic performance (ROC curves) of the original BileLipid classifier and the recalibrated adj.BileLipid model (refitted using Cohort 3 quantification data). Waterfall plots displaying predicted CCA probabilities for Cohort 3 patients using (d) BileLipid and (e) adj.BileLipid classifiers.

Back to article page